Aquestive Therapeutics, Inc. AQST Total Operating Expenses
Discontinued — last reported Q4 '22
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Aquestive Therapeutics, Inc.’s 10-K, filed March 31, 2023, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s total operating expenses?
- Aquestive Therapeutics, Inc. (AQST) reported total operating expenses of $22.44M in Q4 2022.
- How has Aquestive Therapeutics, Inc.'s total operating expenses changed year-over-year?
- Aquestive Therapeutics, Inc.'s total operating expenses increased by 5.0% year-over-year, from $21.38M to $22.44M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.